Here’s Who Is Buying Landauer Inc. (NYSE:LDR) Shares

0
304

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Landauer Inc (NYSE:LDR) reported that  Gilead Capital Lp has picked up 481,415 of common stock as of 2016-12-19.

The acquisition brings the aggregate amount owned by Gilead Capital Lp to a total of 481,415 representing a 5.00 % stake in the company.

For those not familiar with the company, Landauer, Inc. is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products. The Company provides radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries.

A glance at Landauer Inc. (NYSE:LDR)’s key stats reveals a current market capitalization of $441.43 million based on 9.62 million shares outstanding and a price at last close of $47.00 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2015-12-28, Kaminski picked up 1,409 shares at a purchase price of $31.67. This brings their total holding to 7,434 as of the date of the filing.

On the sell side, the most recent transaction saw Singer unload 2,581 shares at a sale price of $60.05. This brings their total holding to 15,571 shares.   .

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Landauer Inc. (NYSE:LDR) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.